HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
WULF
TeraWulf Inc.
There isn't enough reported data to score WULF yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
WULF Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| N/A | |
| N/A |
WULF's revenue is currently healthy, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like WULF.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
WULF PE Valuation
WULF has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
WULF Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect WULF's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over WULF on earnings, with more consistent year-over-year improvement.
WULF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.30 | -$1.87 |
| Q2 2026 | -$4.40 | -$4.04 |
| Q1 2026 | -$2.51 | -$2.17 |
| Q4 2025 | -$1.66 | -$1.45 |
| Q3 2025 | -$1.43 | -$1.29 |
| Q2 2025 | -$0.36 | -$0.19 |
| Q1 2025 | -$0.34 | -$0.12 |
| Q4 2024 | -$0.21 | +$0.14 |
WULF lost $3.30 per share over the past year, a bigger loss than the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over WULF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over WULF on profitability, with a higher operating margin.
WULF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $76.2M | +51% |
| Q2 2026 | $44.8M | -6% |
| Q1 2026 | $34M | -1.1% |
| Q4 2025 | $35.8M | +2.4% |
| Q3 2025 | $50.6M | +87% |
| Q2 2025 | $47.6M | +34% |
| Q1 2025 | $34.4M | -19% |
| Q4 2024 | $35M | +50% |
WULF's revenue is growing: $76M last quarter, up 51% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -116% | -67 points |
| Q2 2026 | -314% | -281 points |
| Q1 2026 | -477% | -303 points |
| Q4 2025 | -241% | -94 points |
| Q3 2025 | -49% | +9.3 points |
| Q2 2025 | -33% | -14 points |
| Q1 2025 | -173% | -168 points |
| Q4 2024 | -147% | -127 points |
WULF's operating margin was −116% last quarter, down 67 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over WULF on cash generation, producing positive trailing cash flow while its opponent burns cash.
WULF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$876.9M | -$608.7M |
| Q2 2026 | -$992.3M | -$817.5M |
| Q1 2026 | -$540.5M | -$503.3M |
| Q4 2025 | -$703.2M | -$506.8M |
| Q3 2025 | -$268.3M | -$226.6M |
| Q2 2025 | -$174.8M | -$144.5M |
| Q1 2025 | -$37.2M | -$13.1M |
| Q4 2024 | -$196.4M | -$173.5M |
WULF's free cash flow was −$3.1B over the past year, against −$677M the year before. Free cash flow isn't a meaningful measure for financial services companies like WULF.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over WULF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
WULF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +18% | +87.9M shares |
| 1 year | +43% | +172M shares |
| 3 years | +173% | +363M shares |
| 5 years | +28923% | +572M shares |
| Available history | +28866% | +572M shares |
WULF has 574M diluted shares, up 43% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $33.3M |
| Q4 2021 | — |
WULF hasn't bought back shares in the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
WULF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -1.0x | Net Cash |
| Q2 2024 | -1.4x | Net Cash |
| Q1 2024 | 3.5x | Elevated |
| Q4 2021 | 32.9x | High |
WULF has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like WULF.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
WULF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.6 | Neutral |
| Stochastic | 24.3 | Neutral |
WULF's weekly RSI is 41 (neutral) and its Stochastic is 24 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
WULF PE vs Financial Services Sector
| Metric | WULF | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
WULF has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
WULF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 0.2% above |
| 20 week MA | $15.9 | 18% below |
| 50 week MA | $17.1 | 24% below |
| 100 week MA | $11.9 | 9.7% above |
| 200 week MA | $7.29 | 79% above |
WULF has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
WULF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.42 | $6.48 | +20% |
| 2021 | $6.48 | $14.4 | +122% |
| 2022 | $14.4 | $0.77 | -95% |
| 2023 | $0.77 | $2.40 | +212% |
| 2024 | $2.40 | $5.53 | +130% |
| 2025 | $5.53 | $11.8 | +112% |
| 2026 YTD | $11.8 | $13.0 | +11% |
WULF has the edge over HIMS on returns for 2026, with the stronger performance.